Michigan 2025-2026 Regular Session Status: Introduced 1 R cosponsors

HB 4969 — Food: other; regulation of distribution, sale, and manufacturing of kratom products; provide for. Creates new act.

Last action — re-referred to Committee on Regulatory Reform

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced June 10, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Not enough signal yet

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

The bill regulates the distribution, sale, and manufacturing of kratom products.

This bill establishes rules for how kratom products are distributed, sold, and manufactured. It aims to create a framework for overseeing these products in the market.

What this means for you
  • Consumers: This means consumers will see regulated kratom products that may improve safety and quality.
  • Small Business: Small businesses involved in kratom may need to comply with new distribution and manufacturing rules.

Summary

Food: other; regulation of distribution, sale, and manufacturing of kratom products; provide for. Creates new act.

Bill Text

What changed in the latest version

107 added · 185 removed

Plain-language change summary

The updated version of Bill HB 4969 now focuses on regulating kratom and kratom products by specifically prohibiting the manufacturing, processing, distribution, and sale of certain products. It introduces requirements for labeling and defines terms related to kratom more clearly, such as "kratom extract" and "kratom leaf." This change is significant because it establishes clearer guidelines around the safety and legality of kratom products, which can help protect consumers from potentially harmful substances. Additionally, it aims to ensure that kratom products are manufactured and sold in a regulated manner, enhancing public safety.

→
Previous
Latest
HOUSE BILL NO.
SUBSTITUTE FOR HOUSE BILL NO.
4969 September 17, 2025, Introduced by Reps.
4969 A bill to regulate certain conduct related to kratom and kratom products;
Cavitt, Borton, Prestin, Martin, Johnsen, Wilson, Woolford, St.
to prohibit the manufacturing, processing, distribution, and sale of certain kratom products;
Germaine, Kunse, Steckloff, Roth, Wortz, Glanville, T.
to require labeling of certain kratom products;
Carter, Pavlov, McKinney, Breen, Snyder, Mueller, Harris, Bruck, Mentzer, Witwer, Brixie, BeGole and Rogers and referred to Committee on Regulatory Reform.
and to prescribe fines.
A bill to regulate the distribution, sale, and manufacture of kratom products;
to require licensing for certain conduct related to kratom and kratom products;
to prohibit the distribution, sale, and manufacturing of certain kratom products;
to provide for the powers and duties of certain state governmental officers and entities;
to prescribe fines and sanctions;
to provide remedies;
and to require the promulgation of rules.
This act may be cited as the "kratom consumer RMH H04479'25_HB4969_INTR_1 c2nxqz 1 protection and regulatory act".
This act may be cited as the "kratom consumer protection act".
(a) "Certificate of licensure" means a document issued as evidence of authorization to distribute, sell, or manufacture a kratom product.
(a) "Certified independent third-party laboratory" means a laboratory that is accredited to the International Organization for Standardization, ISO/IEC 17025 standard, by an accreditation body recognized by the International Laboratory Accreditation Cooperation.
(b) "Department" means the department of licensing and regulatory affairs.
RMH H04479'25 (H-2) 87n5op 1 (b) "Kratom extract" means a substance or compound that meets all of the following criteria:
(c) "Director" means the director of the department or the director's designee.
(i) Is obtained by extraction of the Mitragyna speciosa leaf.
(d) "Food" means that term as defined in section 1107 of the food law, 2000 PA 92, MCL 289.1107.
(ii) Contains more than trace amounts of Mitragyna speciosa and other alkaloids of the Mitragyna speciosa plant.
(e) "Kratom product" means a food that contains any part of the leaf of the plant Mitragyna speciosa.
(iii) Is intended for ingestion.
(f) "License" means an authorization granted by the department under this act to distribute, sell, or manufacture a kratom product.
(iv) Does not contain any controlled substances or levels of residual solvents higher than is allowed under the United States Pharmacopeia 467.
(g) "Licensee" means a person that holds a license.
(c) "Kratom leaf" means the leaf of the Mitragyna speciosa plant in fresh or dehydrated form.
(h) "Rule" means a rule promulgated under the administrative procedures act of 1969, 1969 PA 306, MCL 24.201 to 24.328.
(d) "Kratom product" means a consumable product that contains any part of the kratom leaf or kratom extract.
A kratom product is not considered a food under the food law, 2000 PA 92, MCL 289.1101 to 289.8111.
(1) Beginning January 1, 2027, a person shall not do any of the following unless the person holds a license:
A person that sells a kratom product must label the kratom product, and the label must clearly and conspicuously provide the following information:
(a) Distribute a kratom product in this state.
(a) The following statements:
(b) Sell a kratom product in this state.
(i) A statement against the use of the kratom product by individuals who are under 21 years, who are pregnant, or who are breastfeeding.
(c) Manufacture a kratom product in this state.
(ii) A statement that kratom may be habit forming.
(2) A person shall obtain a license for each location in which the person distributes, sells, or manufacturers a kratom product in this state.
(iii) A statement that reads as follows:
A person shall obtain a license if the person distributes, sells, or offers to distribute or sell a kratom product through an online website to a person in this state.
"These statements have not been evaluated by the Food and Drug Administration.
RMH H04479'25_HB4969_INTR_1 c2nxqz 1 (3) A person applying for a license under this section shall submit an application on a form and in a manner prescribed by the department.
This product is not intended to diagnose, treat, cure, or prevent any disease." (b) Directions for use of the kratom product that include, but are not limited to, all of the following:
An application must include all of the following information:
RMH H04479'25 (H-2) 87n5op 1 (i) A recommended serving size that is clearly described on the label for each form of kratom product, such as capsules, gummies, prepacked single-serving units, or similar product forms.
(a) The applicant's full name, date of birth, telephone number, and address.
If the kratom product is a beverage, liquid, or loose powder, the label must include clear instructions or a mark on the package or container that clearly designates the recommended serving size.
If the applicant is not an individual, the application must include the EIN number of the applicant.
(ii) The recommended number of servings that can be safely consumed in a 24-hour period.
(b) The address of each business or location where a kratom product will be distributed, sold, or manufactured or offered for distribution or sale.
(iii) The recommended number of servings per container.
(c) A list of the kratom products that will be distributed, sold, or manufactured or offered for distribution or sale at each business or location described under subdivision (b).
(iv) A list of the kratom alkaloid content and other ingredients in the kratom product that includes quantitative, not to exceed declarations of the amount per serving of each of the following:
(d) A copy of the certificate of analysis received under section 13.
(A) Mitragynine.
(e) A statement that the information supplied by the applicant is, to the best of the applicant's knowledge, true and is signed under penalty of perjury.
(B) 7-hydroxymitragynine.
(4) The department shall grant an applicant a license under this section if the applicant does all of the following:
(a) Submits a completed application under subsection (3).
(b) Submits an application fee of $200.00.
(c) Meets the qualifications for a license as specified under this act.
Show all 94 changed rows (54 more)
Previous
Latest
(5) The department shall approve or deny an application for a license not later than 30 business days after a completed application is received.
The department shall deny an application for a license if the application is incomplete.
(6) If the department denies an application for a license RMH H04479'25_HB4969_INTR_1 c2nxqz 1 because the application is incomplete, the department shall notify the applicant in writing of the denial not later than 30 business days after the application is received, state the deficiency, and request additional information.
(7) A license is not transferable and is valid for 3 years.
(8) To renew a license, an applicant must do both of the following:
(a) Submit a completed application under subsection (3).
(b) Submit a renewal fee of $125.00.
(9) A licensee shall prominently display the certificate of licensure at each business or location where kratom products are distributed, sold, or manufactured or offered for distribution or sale.
A kratom product must be labeled, and the label must contain the following information:
A person shall not manufacture, process, distribute, sell, or offer for sale or distribution, in person or through an online website, any of the following:
(a) Both of the following statements:
(a) A kratom product that contains a level of 7- hydroxymitragynine in the alkaloid fraction that is greater than 2% of the alkaloid composition of the kratom product.
(i) "Mitragyna speciosa is an unapproved dietary ingredient.
(b) A kratom product that contains a synthesized material, such as an alkaloid, metabolite, or alkaloid derivative that is created by chemical synthesis or biosynthetic means, which includes, but is not limited to, fermentation, recombinant techniques, yeast-derived, or enzymatic techniques, rather than traditional food preparation techniques, such as heating or extracting, that synthetically alters the composition of kratom alkaloid or constituent.
Ingesting Mitragyna speciosa may be dangerous.
RMH H04479'25 (H-2) 87n5op 1 (c) A kratom product that does not include on its package or label the amount of mitragynine and 7-hydroxymitragynine contained in the kratom product.
Consult your physician about whether this product is for you, how to use this product safely, potential interactions, precautionary measures before considering this product, and potential dependency, seizures, and other possible complications.
(d) A kratom product that contains a kratom extract that was manufactured using extraction solvents that contain levels of residual solvents higher than is allowed under the United States Pharmacopeia 467 and not manufactured using food-grade solvents approved by the United States Food and Drug Administration.
Inform your physician of the alkaloid content labeled on this package.".
Sec.
(ii) "Keep out of reach of children.
DO NOT USE IF YOU ARE PREGNANT, PLAN TO BECOME PREGNANT, OR WHILE BREASTFEEDING.
NOT FOR SALE TO MINORS.".
(b) The alkaloid content in the kratom product.
(c) The amount of mitragynine and 7-hydroxymitragynine contained in the kratom product.
RMH H04479'25_HB4969_INTR_1 c2nxqz 1 Sec.
A person shall not distribute, sell, manufacture or offer for distribution or sale in person or through an online website any of the following:
(1) Before a kratom product can be distributed, sold, or offered for distribution or sale, a person that manufactures or processes a kratom product shall have the kratom product tested by a certified independent third-party laboratory to ensure that the kratom product complies with the requirements of this act.
(a) A kratom product that is adulterated with a dangerous nonkratom substance.
If the kratom product complies with the requirements of this act, the certified independent third-party laboratory shall issue the person a certificate of analysis.
A kratom product is adulterated with a dangerous nonkratom substance if the kratom product is mixed or packed with a nonkratom substance and that substance affects the quality or strength of the kratom product to such a degree as to render the kratom product injurious to a consumer.
(2) The person shall maintain a certification of analysis issued under this section for 10 years and make the certificate of analysis available to a law enforcement officer on request.
(b) A kratom product that is contaminated with a dangerous nonkratom substance.
If a law enforcement officer makes a request to review a certificate of analysis issued under this section, the person shall produce the certificate of analysis within 30 days after the request is made.
A kratom product is contaminated with a dangerous nonkratom substance if the kratom product contains a poisonous or otherwise deleterious nonkratom ingredient, including, but not limited to, any of the substances listed in section 7212 of the public health code, 1978 PA 368, MCL 333.7212.
(c) A kratom product that contains a level of 7- hydroxymitragynine in the alkaloid fraction that is greater than 2% of the alkaloid composition of the product.
(d) A kratom product that contains a synthetic alkaloid, including, but not limited to, any of the following:
(i) Synthetic mitragynine.
(ii) Synthetic 7-hydroxymitragynine.
(iii) Any other synthetically derived compound of the plant Mitragyna speciosa.
(e) A kratom product that does not include on its package or label the amount of mitragynine and 7-hydroxymitragynine contained in the kratom product.
(1) A licensee shall not distribute, sell, or offer for distribution or sale in person or through an online website a RMH H04479'25_HB4969_INTR_1 c2nxqz 1 kratom product to an individual in this state who is less than 21 years of age.
A person that violates section 5, 7, or 9 may be ordered to pay a civil fine of not more than $1,000.00 for the first offense and not more than $5,000.00 for a second or subsequent offense.
(2) A person shall not purchase a kratom product over the internet in this state if the kratom product does not comply with section 9.
The prosecutor of the county in which the violation occurred or the attorney general may bring an action to collect the fine.
Sec.
A fine collected under this section must be exclusively applied to the support of public libraries and county RMH H04479'25 (H-2) 87n5op law libraries in the same manner as is provided by law for penal fines assessed and collected for violation of a penal law of this state.
13.
Final Page RMH H04479'25 (H-2) 87n5op
(1) Before applying for a license under section 5, a person that wishes to distribute, sell, or manufacture or offer for distribution or sale a kratom product shall have a sample of the raw materials used to produce each kratom product tested by a qualified laboratory to certify that the kratom product does not contain any substance in violation of section 9.
(2) If the raw materials tested under subsection (1) do not contain a substance in violation of section 9, the qualified laboratory shall provide the person with a certificate of analysis that states that the raw materials meet the requirements prescribed under this act.
(3) A person shall provide a copy of the certificate of analysis described under subsection (2) to the department with an application for a license under section 5 or on request.
The department may request that a person have a sample of raw materials retested by a qualified laboratory under subsection (1) and provide an updated certificate of analysis.
If the department requests that a person have a sample of raw materials retested under this subsection, the person is responsible for the costs of the testing.
(4) As used in this section, "qualified laboratory" means a laboratory approved by the department by rule.
Sec.
15.
(1) After notice and an opportunity for a hearing under the administrative procedures act of 1969, 1969 PA 306, MCL 24.201 to 24.328, a licensee may be subject to the following:
RMH H04479'25_HB4969_INTR_1 c2nxqz 1 (a) For a violation of section 7, 9, or 11, an administrative fine of not more than $500.00 for the first offense and not more than $1,000.00 for a second or subsequent offense.
(b) In addition to an administrative fine under subsection (a) or for any other violation of this act or a rule promulgated under this act, a denial, limitation, suspension, or revocation of a license.
(2) A person that violates section 5(1) may be ordered to pay a civil fine of not more than $500.00 for the first offense and not more than $1,000.00 for a second or subsequent offense.
(3) In addition to any other action authorized by this act, the director may bring an action to do 1 or more of the following:
(a) Obtain a declaratory judgment that a method, act, or practice is in violation of this act.
(b) Obtain an injunction against a person that is engaging, or about to engage, in a method, act, or practice that violates this act.
Sec.
17.
Not later than January 1, 2028, the department shall promulgate rules under the administrative procedures act of 1969, 1969 PA 306, MCL 24.201 to 24.328, to implement this act.
Final Page RMH H04479'25_HB4969_INTR_1 c2nxqz
⬇ Download PDF
View plain text versions (2)

Action History

  1. re-referred to Committee on Regulatory Reform

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 146 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (146)

146 members have not signed on to this bill.

Show all 146 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

health-insurance agriculture
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 4969 do?
Food: other; regulation of distribution, sale, and manufacturing of kratom products; provide for. Creates new act.
Who sponsors HB 4969?
HB 4969 is sponsored by Cameron Cavitt (Republican).
What is the current status of HB 4969?
This bill has been introduced in the House. Introduced June 10, 2026. It must pass committee before a floor vote.
Where can I track HB 4969?
Track HB 4969 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 4969

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 4969

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →